Table 4.
Norm | CH 7 days | CH 21 days | ANOVA | Trend | |
---|---|---|---|---|---|
Parameter | |||||
HR | 462.2 ± 58.5 | 479.6 ± 83.9 | 477.3 ± 71.4 | 0.89 | 0.7 |
ESP (mm Hg) | 19.2 ± 1.6 | 30.1 ± 5.4 | 30.6 ± 4.7 | <0.0001 | <0.0001 |
EDP (mm Hg) | 1.0 ± 0.4 | 0.7 ± 1.2 | 2.2 ± 1.1 | 0.03 | 0.04 |
ESV (µL) | 31.0 ± 15.4 | 31.1 ± 14.4 | 33.6 ± 12.7 | 0.93 | 0.73 |
EDV (µL) | 47.2 ± 20.2 | 45.2 ± 13.4 | 48.9 ± 19.5 | 0.93 | 0.86 |
SV (µL) | 25.5 ± 4.5 | 23.9 ± 6.2 | 28.5 ± 6.1 | 0.33 | 0.33 |
CO (µL*min−1) | 11847 ± 2893 | 11086 ± 2350 | 13227 ± 1497 | 0.32 | 0.28 |
Ea (mm Hg*µL−1) | 0.8 ± 0.2 | 1.5 ± 0.9 | 1.2 ± 0.5 | 0.11 | 0.22 |
Systolic Indices | |||||
EF (%) | 62.7 ± 22.5 | 58.4 ± 20.4 | 65.0 ± 20.3 | 0.84 | 0.84 |
dP/dt max (mm Hg*sec−1) | 1074 ± 291 | 1909 ± 710 | 1514 ±331 | 0.02 | 0.11 |
SW (mm Hg*µL) | 303.0 ± 45.0 | 422.8 ± 151.5 | 430.7 ± 82.3 | 0.06 | 0.03 |
Ees (mm Hg* µL−1) | 2.0 ± 1.3 | 1.8 ± 1.1 | 1.6 ± 0.7 | 0.22 | 0.52 |
dP/dtmax -EDV (mm Hg*sec−1* µL−1) | 63.2 ± 49.9 | 36.5 ± 30.2 | 22.2 ± 7.4 | 0.19 | 0.08 |
PRSW (mm Hg) | 19.9 ± 11.4 | 24.1 ± 6.6 | 18.8 ± 5.5 | 0.54 | 0.83 |
Diastolic Indices | |||||
-dP/dtmin (mm Hg*sec−1) | 984 ± 204 | 1907 ± 808 | 1564 ± 514 | 0.02 | 0.07 |
Tau (ms) | 10.7 ± 3.3 | 7.9 ± 1.9 | 9.9 ± 2.3 | 0.13 | 0.53 |
RV-PA Coupling | |||||
Ees/Ea | 2.2 ± 1.3 | 1.3 ± 0.9 | 1.5 ± 0.8 | 0.31 | 0.27 |
HR = heart rate; ESP = end-systolic pressure; EDP = end-diastolic pressure; ESV = end-systolic volume; EDV = end-diastolic volume; SV = stroke volume; CO = cardiac output; Ea = arterial elastance; EF = ejection fraction; dP/dtmax = maximum rate of pressure change; SW = stroke work; Ees = end-systolic elastance; PRSW = preload recruitable stroke work; dP/dtmin = minimal rate of pressure change; Tau = isovolumic relaxation constant (Weiss method). Data are from 7 animals/group, except Ees, dP/dtmax-EDV, PRSW, and Ees/Ea which are from 5 animals/group. P-values are for one-way ANOVA (ANOVA) with post-hoc testing for linear trend (Trend).